At the news
? NEUTRALIMPACT 2/10 6-K filed Jul 30, 2026 at 12:25 ET
GSK filed a routine 6-K disclosing that President of Global Supply Chain Regis Simard sold 38,000 ordinary shares at £20.38 on July 29, 2026. The sale is a single PDMR transaction with no material financial impact on the company. This filing is administrative in nature and does not signal any change in GSK's business operations or financial health.
- President of Global Supply Chain Regis Simard sold 38,000 ordinary shares on July 29, 2026
- Sale price was £20.38 per share
- Transaction executed on the London Stock Exchange (XLON)
- Filing is a standard PDMR transaction notification under UK rules
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access